Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $747.31 million. The enterprise value is $374.96 million.
Important Dates
The last earnings date was Thursday, October 9, 2025, after market close.
| Earnings Date | Oct 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NRIX has 76.88 million shares outstanding. The number of shares has increased by 34.77% in one year.
| Current Share Class | 76.88M |
| Shares Outstanding | 76.88M |
| Shares Change (YoY) | +34.77% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 95.46% |
| Float | 61.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.58 |
| Forward PS | 10.88 |
| PB Ratio | 2.01 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.35, with a Debt / Equity ratio of 0.15.
| Current Ratio | 5.35 |
| Quick Ratio | 5.23 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -65.35% and return on invested capital (ROIC) is -40.11%.
| Return on Equity (ROE) | -65.35% |
| Return on Assets (ROA) | -32.24% |
| Return on Invested Capital (ROIC) | -40.11% |
| Return on Capital Employed (ROCE) | -60.72% |
| Revenue Per Employee | $292,612 |
| Profits Per Employee | -$855,892 |
| Employee Count | 286 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $768,000 in taxes.
| Income Tax | 768,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.87% in the last 52 weeks. The beta is 2.34, so NRIX's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -58.87% |
| 50-Day Moving Average | 9.54 |
| 200-Day Moving Average | 12.61 |
| Relative Strength Index (RSI) | 52.45 |
| Average Volume (20 Days) | 1,299,352 |
Short Selling Information
The latest short interest is 13.04 million, so 16.95% of the outstanding shares have been sold short.
| Short Interest | 13.04M |
| Short Previous Month | 13.05M |
| Short % of Shares Out | 16.95% |
| Short % of Float | 21.06% |
| Short Ratio (days to cover) | 12.63 |
Income Statement
In the last 12 months, NRIX had revenue of $83.69 million and -$244.79 million in losses. Loss per share was -$2.97.
| Revenue | 83.69M |
| Gross Profit | -217.42M |
| Operating Income | -267.23M |
| Pretax Income | -244.02M |
| Net Income | -244.79M |
| EBITDA | -259.36M |
| EBIT | -267.23M |
| Loss Per Share | -$2.97 |
Full Income StatementBalance Sheet
The company has $428.83 million in cash and $56.49 million in debt, giving a net cash position of $372.34 million or $4.84 per share.
| Cash & Cash Equivalents | 428.83M |
| Total Debt | 56.49M |
| Net Cash | 372.34M |
| Net Cash Per Share | $4.84 |
| Equity (Book Value) | 372.25M |
| Book Value Per Share | 4.84 |
| Working Capital | 358.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$230.38 million and capital expenditures -$10.98 million, giving a free cash flow of -$241.36 million.
| Operating Cash Flow | -230.38M |
| Capital Expenditures | -10.98M |
| Free Cash Flow | -241.36M |
| FCF Per Share | -$3.14 |
Full Cash Flow StatementMargins
Gross margin is -259.80%, with operating and profit margins of -319.32% and -292.50%.
| Gross Margin | -259.80% |
| Operating Margin | -319.32% |
| Pretax Margin | -291.58% |
| Profit Margin | -292.50% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.77% |
| Shareholder Yield | -34.77% |
| Earnings Yield | -32.76% |
| FCF Yield | -32.30% |
Analyst Forecast
The average price target for NRIX is $28.29, which is 199.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.29 |
| Price Target Difference | 199.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 44.40% |
| EPS Growth Forecast (5Y) | -9.50% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 1.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 4 |
